Cited by 697Histone Deacetylase Inhibitors ResearchGenomics and Chromatin DynamicsEpigenetics and DNA Methylation

The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.

HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics

Gallinari, Paola, Marco, Stefania Di, Jones, Phillip, Pallaoro, Michele, Steinkühler, Christian·2007·Cell Research

Open this paper in CoChat — free account

Abstract

Histone deacetylases (HDACs) and histone acetyl transferases (HATs) are two counteracting enzyme families whose enzymatic activity controls the acetylation state of protein lysine residues, notably those contained in the N-terminal extensions of the core histones. Acetylation of histones affects gene expression through its influence on chromatin conformation. In addition, several non-histone proteins are regulated in their stability or biological function by the acetylation state of specific lysine residues. HDACs intervene in a multitude of biological processes and are part of a multiprotein family in which each member has its specialized functions. In addition, HDAC activity is tightly controlled through targeted recruitment, protein-protein interactions and post-translational modifications. Control of cell cycle progression, cell survival and differentiation are among the most important roles of these enzymes. Since these processes are affected by malignant transformation, HDAC inhibitors were developed as antineoplastic drugs and are showing encouraging efficacy in cancer patients.

Integrity signals

Registry

Crossref · 10.1038/sj.cr.7310149

Cites

165 of 165 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Translating the Histone Code
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
Histone deacetylases (HDACs): characterization of the classical HDAC family
RUIJTER, A. J. M. D., GENNIP, A. H. V., CARON, H. N., KEMP, S., & KUILENBURG, A. B. P. V. (2003) · Biochemical Journal · doi:10.1042/bj20021321 · Cited by 3,114
Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain
Bannister, A. J., Zegerman, P., Partridge, J. F., Miska, E. A., Thomas, J. O., Allshire, R. C., & Kouzarides, T. (2001) · Nature · doi:10.1038/35065138 · Cited by 2,903
Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins
Lachner, M., O'Carroll, D., Rea, S., Mechtler, K., & Jenuwein, T. (2001) · Nature · doi:10.1038/35065132 · Cited by 2,868
DNA methylation and human disease
Robertson, K. D. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1655 · Cited by 2,864
ACETYLATION AND METHYLATION OF HISTONES AND THEIR POSSIBLE ROLE IN THE REGULATION OF RNA SYNTHESIS
Allfrey, V. G., Faulkner, R. D., & Mirsky, A. E. (1964) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.51.5.786 · Cited by 2,788
HDAC6 is a microtubule-associated deacetylase
Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.-F., & Yao, T.-P. (2002) · Nature · doi:10.1038/417455a · Cited by 2,403
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
Minucci, S., & Pelicci, P. G. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1779 · Cited by 2,234
The diverse functions of histone lysine methylation
Martin, C., & Zhang, Y. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1761 · Cited by 2,157
Histone Acetyltransferases
Dent, S., Denu, J. M., & Allis, C. D. (2001) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.70.1.81 · Cited by 1,906

Flagged first, then by citations

Show all 165 references

Research works printed but not linked: 1

Vaisburg A . Discovery and development of MGCD0103 – an orally active HDAC inhibitor in human clinical trials. XIXth International Symposium on Medical Chemistry, Istanbul, Aug 29-Sep 2, 2006.

Sorted by citations

Items 201–300 of 697

New Insight in HDACs: Potential Therapeutic Targets for the Treatment of Atherosclerosis
Luan, Y., Liu, H., Luan, Y., Yang, Y., Yang, J., & Ren, K. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.863677 · Cited by 32
Role of 5'TG3'-interacting factors (TGIFs) in Vorinostat (HDAC inhibitor)-mediated Corneal Fibrosis Inhibition.
Sharma, A., Sinha, N. R., Siddiqui, S., & Mohan, R. R. (2015) · PubMed Central · Cited by 31
Interrogating Substrate Selectivity and Composition of Endogenous Histone Deacetylase Complexes with Chemical Probes
Dose, A., Sindlinger, J., Bierlmeier, J., Bakirbas, A., Schulze‐Osthoff, K., Einsele‐Scholz, S., Hartl, M., Eßmann, F., Finkemeier, I., & Schwarzer, D. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201508174 · Cited by 30
MTA1 expression in human cancers – Clinical and pharmacological significance
Malisetty, V. L., Penugurti, V., Panta, P., Chitta, S. K., & Manavathi, B. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.09.025 · Cited by 30
HDAC8 Deacetylates HIF-1α and Enhances Its Protein Stability to Promote Tumor Growth and Migration in Melanoma
Kim, J. Y., Cho, H., Yoo, J. H., Kim, G. W., Jeon, Y. H., Lee, S. W., & Kwon, S. H. (2023) · Cancers · doi:10.3390/cancers15041123 · Cited by 30
Dietary, Metabolic, and Potentially Environmental Modulation of the Lysine Acetylation Machinery
Kim, G.-W., Gocevski, G., Wu, C.-J., & Yang, X. (2010) · International Journal of Cell Biology · doi:10.1155/2010/632739 · Cited by 34
Role of ND10 nuclear bodies in the chromatin repression of HSV-1
Gu, H., & Zheng, Y. (2016) · Virology Journal · doi:10.1186/s12985-016-0516-4 · Cited by 30
“HDAC phosphorylation affects its interactions to its binding partners, such as CoREST, and therefore regulates gene expression in signal transduction and cell cycle control [112].”
Systematically Mitigating the p38α Activity of Triazole-based BET Inhibitors
Carlson, A. S., Cui, H., Divakaran, A., Johnson, J. A., Brunner, R. M., Pomerantz, W. C. K., & Topczewski, J. J. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00227 · Cited by 30
Role of epigenetic alterations in aflatoxin‐induced hepatocellular carcinoma
Mungamuri, S. K., & Mavuduru, V. A. (2020) · Liver Cancer International · doi:10.1002/lci2.20 · Cited by 30
Recent Developments in the Synthesis and Anticancer Activity of Indole and Its Derivatives
Wadhwa, P. K., Kaur, B., Venugopal, S., Verma, A., Sahu, S. K., Kumar, D., & Sharma, A. K. (2022) · Current Organic Synthesis · doi:10.2174/1570179419666220509215722 · Cited by 30
Preclinical Studies on Histone Deacetylase Inhibitors as Therapeutic Reagents for Endometrial and Ovarian Cancers
Singh, B. N., Zhou, H., Li, J., Tipton, T., Wang, B., Shao, G., Gilbert, E. N., Li, Q., & Jiang, S. (2011) · Future Oncology · doi:10.2217/fon.11.124 · Cited by 30
Histone Deacetylase Inhibition with Trichostatin a does not Reverse Severe Angioproliferative Pulmonary Hypertension in Rats (2013 Grover Conference Series)
de Raaf, M. A., Alhussaini, A. A., Gomez‐Arroyo, J. G., Kraskaukas, D., Farkas, D., Happé, C. M., Voelkel, N. F., & Bogaard, H. J. (2014) · Pulmonary Circulation · doi:10.1086/675986 · Cited by 30
Alternative Modes of Binding of Recombinant Human Histone Deacetylase 8 to Colloidal Gold Nanoparticles
Sule, N., Singh, P., & Srivastava, D. K. (2008) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2008.011 · Cited by 30
Proteinase‐Activated Receptor‐2 Modulates Ve‐Cadherin Expression to Affect Human Vascular Endothelial Barrier Function
Zhang, R., & Ge, J. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26123 · Cited by 30
“Since HDAC plays an important role in the regulation of gene transcription [Gallinari et al., 2007], the data indicate that activation of PAR2 is associated with the regulation of gene transcription viamodulating the activities of HDAC.”
BackgroundInfluential
Relationship Between Histone Deacetylase 3 (HDAC3) and Breast Cancer
Cui, Z., Xie, M., Wu, Z., & Shi, Y. (2018) · Medical Science Monitor · doi:10.12659/msm.906576 · Cited by 32
Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment
Berndsen, R. H., Abdul, U. K., Weiss, A., Zoetemelk, M., Winkel, M. T. T., Dyson, P. J., Griffioen, A. W., & Nowak-Sliwinska, P. M. (2017) · Angiogenesis · doi:10.1007/s10456-017-9551-z · Cited by 29
Quinazoline‐Based Hydroxamic Acids: Design, Synthesis, and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity
Hieu, D. T., Anh, D. T., Pham‐The, H., Le‐Thi‐Thu, H., Park, E. J., Choi, J. E., Kang, J. S., Dung, P. T. P., Han, S., & Nam, N. (2018) · Chemistry & Biodiversity · doi:10.1002/cbdv.201800027 · Cited by 29
Indole: A Privileged Heterocyclic Moiety in the Management of Cancer
Mir, R. H., Mohi-ud-din, R., Wani, T. U., Dar, M. O., Shah, A. J., Lone, B. A., Chawla, P. A., & Masoodi, M. H. (2021) · Current Organic Chemistry · doi:10.2174/1385272825666210208142108 · Cited by 29
CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway
Huang, W., Zhang, J., Huo, M., Gao, J., Yang, T., Yin, X., Wang, P., Leng, S., Feng, D., Chen, Y., et al. (2021) · Advanced Science · doi:10.1002/advs.202001515 · Cited by 29
Preoperative environment enrichment preserved neuroligin 1 expression possibly via epigenetic regulation to reduce postoperative cognitive dysfunction in mice
Jia, M., Lai, Z., Wang, H., & Zuo, Z. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13777 · Cited by 29
Role of Selective Histone Deacetylase 6 Inhibitor ACY-1215 in Cancer and Other Human Diseases
Li, J., Yu, M., Fu, S., Liu, D., & Tan, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.907981 · Cited by 29
Targeting protein acetylation for improving cancer therapy.
Dwarakanath, B. S. R., Verma, A., Bhatt, A. N., Parmar, V. S., & Raj, H. G. (2008) · PubMed · Cited by 29
Chromatin, photoperiod and the Arabidopsis circadian clock: A question of time
Stratmann, T., & Más, P. (2008) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2008.07.012 · Cited by 29
Papillomavirus binding factor binds to SAP30 and represses transcription via recruitment of the HDAC1 co-repressor complex
Sichtig, N., Körfer, N., & Steger, G. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.08.015 · Cited by 29
Histone deacetylase inhibitors and their potential role in inflammatory bowel diseases
Edwards, A. J. P., & Pender, S. L. F. (2011) · Biochemical Society Transactions · doi:10.1042/bst0391092 · Cited by 29
Immunological role and underlying mechanisms of B7‐H6 in tumorigenesis
Hu, Y., Zeng, T., Zheng, X. W., Hu, Q.-H., Li, Y., Tan, X., Yue, H., Wang, W., Tan, H., & Zou, J. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.12.030 · Cited by 28
Screening for gene expression fluctuations reveals latency-promoting agents of HIV
Lu, Y., Bohn-Wippert, K., Pazerunas, P. J., Moy, J. M., Singh, H., & Dar, R. D. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012191118 · Cited by 28
“Shock and kill faces many obstacles: 1) LRAs impair cytotoxic T cell function (5 – 7), 2) many of the currently available LRAs exhibit toxic effects and affect global gene expression (8), and 3) LRAs activate a limited percentage of the total reservoir on each exposure (9).”
HDAC as a Therapeutic Target for Treatment of Endometrial Cancers
Ren, J., Zhang, J., Cai, H., Li, Y., Zhang, Y., Zhang, X., Zhao, D., Li, Z., Ma, H., Wang, J., et al. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990528 · Cited by 28
Cigarette smoke extract modulates Pseudomonas aeruginosa bacterial load via USP25/HDAC11 axis in lung epithelial cells
Chen, L., Lai, Y., Li, T., Nyunoya, T., & Zou, C. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00142.2019 · Cited by 28
AMPK-mediated CD47 H3K4 methylation promotes phagocytosis evasion of glioma stem cells post-radiotherapy
Sun, T., Liu, B., Cao, Y., Li, Y., Cai, L., & Yang, W. (2024) · Cancer Letters · doi:10.1016/j.canlet.2023.216605 · Cited by 27
Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
Sudo, M., Chin, T. M., Mori, S., Doan, N., SAID, J. W., Akashi, M., & Koeffler, H. P. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-013-2132-y · Cited by 28
“The lack of effect on constitutively activated p-Akt in these cells may be explained because H460 cells have a mutation of PI3K and KRAS [16].”
BackgroundInfluential
A CRISPR-Cas9 repressor for epigenetic silencing of KRAS
Liu, J., Sun, M., Cho, K. B., Gao, X., & Guo, B. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105304 · Cited by 28
Inhibition of HDAC6 by Tubastatin A reduces chondrocyte oxidative stress in chondrocytes and ameliorates mouse osteoarthritis by activating autophagy
Shen, Z., Ji, K., Cai, Z., Huang, C., He, X., Xu, H., & Chen, G. (2021) · Aging · doi:10.18632/aging.202736 · Cited by 27
Post-translational lysine ac(et)ylation in health, ageing and disease
Blasl, A., Schulze, S., Qin, C., Graf, L. G., Vogt, R., & Lammers, M. (2021) · Biological Chemistry · doi:10.1515/hsz-2021-0139 · Cited by 30
“autophagy, chromatin remodeling, cell cycle and cytoskeleton dynamics (Gallinari et al. 2007; Lam et al. 2020; Liao et al. 2020; Mrakovcic et al. 2017).”
Background
Regulation of FGF-2, FGF-18 and Transcription Factor Activity by Perlecan in the Maturational Development of Transitional Rudiment and Growth Plate Cartilages and in the Maintenance of Permanent Cartilage Homeostasis
Hayes, A. J., Whitelock, J. M., & Melrose, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23041934 · Cited by 27
“Future studies on nuclear perlecan are warranted to fully determine its potential impact on gene regulation [156].”
Background
Post-Translational Modifications of Histones Are Versatile Regulators of Fungal Development and Secondary Metabolism
Etier, A., Dumetz, F., Chéreau, S., & Ponts, N. (2022) · Toxins · doi:10.3390/toxins14050317 · Cited by 29
Synthesis and biological activity of cyclotetrapeptide analogues of the natural HDAC inhibitor FR235222
Terracciano, S., Micco, S. D., Bifulco, G., Gallinari, P., Riccio, R., & Bruno, I. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.03.022 · Cited by 27
Self-citation
Acetylation and deacetylation of histone in adipocyte differentiation and the potential significance in cancer
Wang, X., Li, N., Zheng, M., Yu, Y., & Zhang, S. (2023) · Translational Oncology · doi:10.1016/j.tranon.2023.101815 · Cited by 25
“HDACs deacetylate nucleosomes and deacetylate histone proteins, which bind tightly to negatively charged DNA; chromatin is densely coiled and is involved in adipocyte differentiation and the maintenance of the preadipocyte phenotype by repressing the transcription of key genes [92].”
Background
The pharmacoepigenetic paradigm in cancer treatment
Ocaña-Paredes, B., Rivera-Orellana, S., Ramírez-Sánchez, D., Montalvo-Guerrero, J., Freire, M. P., Espinoza-Ferrao, S., Altamirano-Colina, A., Echeverría-Espinoza, P., Ramos-Medina, M. J., Echeverría‐Garcés, G., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1381168 · Cited by 28
FRA1:c-JUN:HDAC1 complex down-regulates filaggrin expression upon TNFα and IFNγ stimulation in keratinocytes
Ahn, S. S., Yeo, H., Jung, E., Lim, Y., Lee, Y. H., & Shin, S. Y. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2123451119 · Cited by 26
A Reactivity‐Tunable Self‐Immolative Design Enables Histone Deacetylase‐Targeted Imaging and Prodrug Activation
Liu, F., Ding, X., Xu, X., Wang, F., Chu, X., & Jiang, J. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202203243 · Cited by 25
Recent Advances in Transcription Factors Biomarkers and Targeted Therapies Focusing on Epithelial–Mesenchymal Transition
Chuang, K., Chiou, S., & Hsu, S. (2023) · Cancers · doi:10.3390/cancers15133338 · Cited by 26
Identification of KD5170: A novel mercaptoketone-based histone deacetylase inhibitor
Payne, J. E., Bonnefous, C., Hassig, C. A., Symons, K. T., Guo, X., Nguyen, P.-M., Annable, T., Wash, P. L., Hoffman, T. Z., Rao, T. S., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.10.029 · Cited by 27
Metformin Augments Panobinostat's Anti-Bladder Cancer Activity by Activating AMP-Activated Protein Kinase
Okubo, K., Isono, M., Asano, T., & Sato, A. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.02.001 · Cited by 26
Suberoyl Bishydroxamic Acid Inhibits Cellular Proliferation by Inducing Cell Cycle Arrest in Carcinoid Cancer Cells
Greenblatt, D. Y., Cayo, M. A., Li, N., Jaskula‐Sztul, R., Haymart, M. R., Kunnimalaiyaan, M., & Chen, H. (2007) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-007-0249-1 · Cited by 26
Unlocking the epigenetic code: new insights into triple-negative breast cancer
Mahendran, G., Shangaradas, A. D., Romero-Moreno, R., Dona, N. W., Sarasija, S. H. G. S., Perera, S., & Silva, G. N. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1499950 · Cited by 26
“The e -amino groups of lysine residues (e.g.: H2A; lysine 5,12,15 and 29 of histone H2B; 9,14,18 and 23 of histone H3 and lysine 5,8,12,16 and 20 of histone H4) (95, 96) located in the N-terminal extensions of core histone proteins provide sites for acetylation.”
Involvement of histone acetylation in the regulation of choline acetyltransferase gene in NG108-15 neuronal cells
Aizawa, S., & Yamamuro, Y. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.01.007 · Cited by 25
Silencing PEX26 as an unconventional mode to kill drug-resistant cancer cells and forestall drug resistance
Dahabieh, M. S., Huang, F., Gonçalves, C., González, R. E. F., Prabhu, S. A., Bolt, A. M., Pietro, E. D., Khoury, E., Heath, J., Xu, Z., et al. (2021) · Autophagy · doi:10.1080/15548627.2021.1936932 · Cited by 25
Assessment of Pharmacological Interactions between SIRT2 Inhibitor AGK2 and Paclitaxel in Different Molecular Subtypes of Breast Cancer Cells
Wawruszak, A., Łuszczki, J. J., Czerwonka, A., Okoń, E., & Stepulak, A. (2022) · Cells · doi:10.3390/cells11071211 · Cited by 25
Metabolic Effects of Known and Novel HDAC and SIRT Inhibitors in Glioblastomas Independently or Combined with Temozolomide
Čuperlović‐Culf, M., Touaibia, M., St‐Cœur, P., Poitras, J., Morin, P., & Culf, A. S. (2014) · Metabolites · doi:10.3390/metabo4030807 · Cited by 24
Design, synthesis and biological evaluation of di-substituted cinnamic hydroxamic acids bearing urea/thiourea unit as potent histone deacetylase inhibitors
Ning, C., Bi, Y.-J., He, Y., Huang, W., Liu, L., Li, Y., Zhang, S.-H., Liu, X., & Yu, N. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.09.051 · Cited by 25
Histones: Controlling Tumor Signaling Circuitry
Castilho, M. D. M. R. M. (2013) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.s5-001 · Cited by 24
Studies of the metabolic stability in cells of 5-(trifluoroacetyl)thiophene-2-carboxamides and identification of more stable class II histone deacetylase (HDAC) inhibitors
Scarpelli, R., Marco, A. D., Ferrigno, F., Laufer, R., Marcucci, I., Muraglia, E., Ontoria, J. M., Rowley, M., Serafini, S., Steinkühler, C., et al. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.10.041 · Cited by 25
Self-citation
Quantum polarized ligand docking investigation to understand the significance of protonation states in histone deacetylase inhibitors
Kalyaanamoorthy, S., & Chen, Y. P. (2013) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2013.05.002 · Cited by 25
Recent advancements in the role of histone acetylation dynamics to improve stress responses in plants
Bajpai, S. K., ., N., Pandita, S., Bahadur, A., & Verma, P. C. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09300-3 · Cited by 25
“HDACs strengthen the binding between DNA and histones by removing acetyl functional groups from histone lysine residues [29], preventing transcriptional machinery from accessing the template [30].”
Protein acetylation derepresses Serotonin Synthesis to potentiate Pancreatic Beta-Cell Function through HDAC1-PKA-Tph1 signaling
Zhang, Y., Wang, S., Zhang, L., Zhou, F., Zhu, K., Zhu, Q., Liu, Q., Liu, Y., Jiang, L., Ning, G., et al. (2020) · Theranostics · doi:10.7150/thno.44459 · Cited by 25
“The zinc-dependent HDACs have been shown to form multi-protein complexes to function as transcriptional repressors [5], among which class I and II families play critical roles in regulating metabolic gene programs [6].”
Background
Limb blastema formation: How much do we know at a genetic and epigenetic level?
Min, S., & Whited, J. L. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102858 · Cited by 24
G1/S Cell Cycle Checkpoint Dysfunction in Lymphoblasts from Sporadic Parkinson’s Disease Patients
Esteras, N., Alquézar, C., Bartolomé, F. B., de la Encarnación, A., Bermejo‐Pareja, F., Molina, J. A., & Martín‐Requero, Á. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8870-y · Cited by 24
“Rapamycin and CDK6 inhibitors are already being used as immunosuppressant and for treatment of a number of human tumors, respectively [54, 55], with a good tolerance.”
1‐Arylsulfonyl‐5‐(N‐hydroxyacrylamide)indolines Histone Deacetylase Inhibitors Are Potent Cytokine Release Suppressors
Lee, H., Yang, C., Lai, M.-J., Huang, H.-L., Hsieh, Y., Liu, Y., Yeh, T., Li, Y., Mehndiratta, S., Teng, C., et al. (2013) · ChemBioChem · doi:10.1002/cbic.201300201 · Cited by 24
Histone Deacetylase 8: Characterization of Physiological Divalent Metal Catalysis
Nechay, M. R., Gallup, N. M., Morgenstern, A., Smith, Q. A., Eberhart, M. E., & Alexandrova, A. N. (2016) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.6b00997 · Cited by 25
Histone Posttranslational Modifications of CD4+ T Cell in Autoimmune Diseases
Wang, Z., Yin, H., Lau, C. S., & Lu, Q. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101547 · Cited by 23
Quinazolin‐4(3H)‐one‐Based Hydroxamic Acids: Design, Synthesis and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity
Hieu, D. T., Anh, D. T., Pham‐The, H., Thuần, N. T. D., Le‐Thi‐Thu, H., Park, E. J., Ji, A. Y., Kang, J. S., Dung, P. T. P., Han, S., et al. (2019) · Chemistry & Biodiversity · doi:10.1002/cbdv.201800502 · Cited by 24
Design, synthesis and biological evaluation of 4-anilinothieno[2,3-d]pyrimidine-based hydroxamic acid derivatives as novel histone deacetylase inhibitors
Yang, W., Li, L., Ji, X., Wu, X., Su, M., Li, S., Zang, Y., Li, J. X., & Liu, H. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.08.030 · Cited by 24
Epigenetic Dysregulation in Cancer: Implications for Gene Expression and DNA Repair-Associated Pathways
Rembiałkowska, N., Rekiel, K., Urbanowicz, P., Mamala, M. B., Marczuk, K. M., Wojtaszek, M., Żywica, M., Radzevičiūtė-Valčiukė, E., Novickij, V., & Kulbacka, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136531 · Cited by 34
“In contrast, histone deacetylation promotes a more condensed chromatin state (heterochromatin) associated with transcriptional repression [32].”
Specific epigenetic regulators serve as potential therapeutic targets in idiopathic pulmonary fibrosis
Sehgal, M., Jakhete, S. M., Manekar, A. G., & Sasikumar, S. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09773 · Cited by 23
Identification of a novel PAK1/HDAC6 dual inhibitor ZMF-23 that triggers tubulin-stathmin regulated cell death in triple negative breast cancer
Zhang, J., Chen, X., Chen, G., Wang, H., Jia, L., Yue, H., & Yao, D. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.126348 · Cited by 24
Epigenetics in dilated cardiomyopathy
Yu, J., Zeng, C., & Wang, Y. (2019) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000616 · Cited by 23
Chromatin dynamics during liver regeneration
Arechederra, M., Berasain, C., Avila, M. A., & Fernández-Barrena, M. G. (2020) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2019.03.004 · Cited by 28
Effect of maternal zinc deficiency on offspring health: The epigenetic impact
Sanusi, K. O., Ibrahim, K. G., Abubakar, B., Malami, I., Bello, M. B., Imam, M. U., & Abubakar, M. B. (2021) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2021.126731 · Cited by 22
First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Selective Inhibitors with Cellular Target Engagement**
Herp, D., Ridinger, J., Robaa, D., Shinsky, S. A., Schmidtkunz, K., Yesiloglu, T. Z., Bayer, T., Steimbach, R. R., Herbst‐Gervasoni, C. J., Merz, A., et al. (2022) · ChemBioChem · doi:10.1002/cbic.202200180 · Cited by 22
Maspin expression in prostate tumor elicits host anti-tumor immunity
Dzinic, S. H., Chen, K., Thakur, A. B., Kaplun, A., Bonfil, R. D., Li, X., Liu, J., Bernardo, M. M., Saliganan, A. D., Back, J. B., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.2615 · Cited by 22
New macrocyclic analogs of the natural histone deacetylase inhibitor FK228; design, synthesis and preliminary biological evaluation
Ni, M., Esposito, E., Raj, V. P., Muzi, L., Zunino, F., Zuco, V., Cominetti, D., Penco, S., & Pozzo, A. D. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.10.004 · Cited by 22
Droxinostat, a Histone Deacetylase Inhibitor, Induces Apoptosis in Hepatocellular Carcinoma Cell Lines via Activation of the Mitochondrial Pathway and Downregulation of FLIP
Liu, J., Li, G., Wang, X., Wang, L., Zhao, R., Wang, J., Kong, Y., Ding, J., Li, J., & Zhang, L. (2016) · Translational Oncology · doi:10.1016/j.tranon.2016.01.004 · Cited by 22
Targeting prostate cancer cells with enzalutamide‐HDAC inhibitor hybrid drug 2‐75
Hu, W., Xu, L., Chen, B., Ou, S., Muzzarelli, K. M., Hu, D., Li, Y., Yang, Z., Griend, D. J. V., Prins, G. S., et al. (2019) · The Prostate · doi:10.1002/pros.23832 · Cited by 22
Histone deacetylase 3 facilitates TNFα-mediated NF-κB activation through suppressing CTSB induced RIP1 degradation and is required for host defense against bacterial infection
Yang, L., Chen, S., Xia, J., Zhou, Y., Peng, L., Fan, H., Han, Y., Duan, L., Cheng, G., Yang, H., et al. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00814-6 · Cited by 21
Genome Editing Approaches with CRISPR/Cas9 for Cancer Treatment: Critical Appraisal of Preclinical and Clinical Utility, Challenges, and Future Research
Chira, S., Nutu, A. M., Isachesku, E., Bica, C., Pop, L., Ciocan, C. A., & Berindan‐Neagoe, I. (2022) · Cells · doi:10.3390/cells11182781 · Cited by 24
Progress in discovery and development of natural inhibitors of histone deacetylases (HDACs) as anti-cancer agents
Wahi, A., Jain, P., Sinhari, A., & Jadhav, H. R. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02674-4 · Cited by 23
Interrogating epigenetic mechanisms with chemically customized chromatin
Hananya, N., Koren, S., & Muir, T. W. (2023) · Nature Reviews Genetics · doi:10.1038/s41576-023-00664-z · Cited by 20
“HDACs and KDMs are regulated through various mechanisms, including PTMs, protein–protein interaction-mediated recruitment and sensing the existing nucleosome landscape by auxiliary reader domains 60,61 .”
Sodium butyrate, a histone deacetylase inhibitor, regulates Lymphangiogenic factors in oral cancer cell line HSC-3.
Yamamura, T., Matsumoto, N., Matsue, Y., Okudera, M., Nishikawa, Y., Abiko, Y., & Komiyama, K. (2014) · PubMed · Cited by 21
Beyond Histones: New Substrate Proteins of Lysine Deacetylases in Arabidopsis Nuclei
Füßl, M., Lassowskat, I., Née, G., Koskela, M. M., Brünje, A., Tilak, P., Giese, J., Leister, D., Mulo, P., Schwarzer, D., et al. (2018) · Frontiers in Plant Science · doi:10.3389/fpls.2018.00461 · Cited by 21
“Furthermore, KDAC inhibitors can enhance the resistance to salinity in plants, and in humans they are used in cancer therapy (Gallinari et al., 2007; Ueda et al., 2017).”
Background
Histone deacetylase inhibition and the regulation of cell growth with particular reference to liver pathobiology
Fraczek, J., van Grunsven, L. A., Vinken, M., Sarah, S., Deleu, S., Vanderkerken, K., Vanhaecke, T., & Rogiers, V. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00831.x · Cited by 21
Identification of predictive biomarkers for the histone deacetylase inhibitor belinostat in a panel of human cancer cell lines
Dejligbjerg, M., Grauslund, M., Christensen, I. J., Tjørnelund, J., Jensen, P. B., & Sehested, M. (2008) · Cancer Biomarkers · doi:10.3233/cbm-2008-4206 · Cited by 21
Global histone profiling by LC–FTMS after inhibition and knockdown of deacetylases in human cells
Li, M., Jiang, L., & Kelleher, N. L. (2009) · Journal of Chromatography B · doi:10.1016/j.jchromb.2009.09.042 · Cited by 21
Targeting Class I Histone Deacetylases in Human Uterine Leiomyosarcoma
Yang, Q., Falahati, A., Khosh, A., Mohammed, H., Kang, W., Corachán, A., Bariani, M. V., Boyer, T., & Al-Hendy, A. A. (2022) · Cells · doi:10.3390/cells11233801 · Cited by 19
Can Cryopreservation in Assisted Reproductive Technology (ART) Induce Epigenetic Changes to Gametes and Embryos?
Sciorio, R., Manna, C., Fauque, P., & Rinaudo, P. F. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12134444 · Cited by 20
Histone Deacetylase (HDAC)-1, -2, -4, and -6 in Uveal Melanomas: Associations with Clinicopathological Parameters and Patients’ Survival
Levidou, G., Gajdzis, P., Cassoux, N., Donizy, P., Masaoutis, C., Gajdzis, M., Gardrat, S., Pergaris, A., Danas, E., Klijanienko, J., et al. (2021) · Cancers · doi:10.3390/cancers13194763 · Cited by 20
Development and validation of the TGx-HDACi transcriptomic biomarker to detect histone deacetylase inhibitors in human TK6 cells
Cho, E., Rowan‐Carroll, A., Williams, A., Corton, J. C., Li, H., Fornace, A. J., Hobbs, C. A., & Yauk, C. L. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03014-2 · Cited by 19
Epigenetic Regulation of Autophagy in Cardiovascular Pathobiology
Bu, S., & Singh, K. K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126544 · Cited by 19
Nucleotide Metabolism Behind Epigenetics
Suganuma, T., & Workman, J. L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.731648 · Cited by 18
“dinucleotide, NAD, as a co-substrate and transfer the acetyl group onto adenosine diphosphate ribose (ADPR) to form a 2’-Oacetyl-ADPR (8, 9).”
Background
Silencing BRE Expression in Human Umbilical Cord Perivascular (HUCPV) Progenitor Cells Accelerates Osteogenic and Chondrogenic Differentiation
Chen, E., Tang, F. M. K., Yao, Y., Yau, W. W. Y., Lo, L. M., Yang, X., Chui, Y., Chan, J. Y.-H., & Lee, K. K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067896 · Cited by 19
Effect of histone deacetylase inhibitor on proliferation of biliary tract cancer cell lines
Xu, L., Wang, X., & Zou, S.-Q. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.2578 · Cited by 19
Modulation of immunoglobulin gene conversion frequency and distribution by the histone deacetylase HDAC2 in chicken DT40
Lin, W., Hashimoto, S., Seo, H., Shibata, T., & Ohta, K. (2008) · Genes to Cells · doi:10.1111/j.1365-2443.2008.01166.x · Cited by 19
Revealing the biophysics of lamina-associated domain formation by integrating theoretical modeling and high-resolution imaging
Dhankhar, M., Guo, Z., Kant, A., Basir, R., Joshi, R., Vinayak, V., Heo, S., Mauck, R. L., Lakadamyali, M., & Shenoy, V. B. (2025) · Nature Communications · doi:10.1038/s41467-025-63244-1 · Cited by 18
“4A) 43 .”
Simvastatin-romidepsin combination kills bladder cancer cells synergistically
Okubo, K., Miyai, K., Kato, K., Asano, T., & Sato, A. (2021) · Translational Oncology · doi:10.1016/j.tranon.2021.101154 · Cited by 19
Improved HDAC Inhibition, Stronger Cytotoxic Effect and Higher Selectivity against Leukemias and Lymphomas of Novel, Tricyclic Vorinostat Analogues
Bieszczad, B., Garbicz, D., Świtalska, M., Dudek, M. K., Warszycki, D., Wietrzyk, J., Grzesiuk, E., & Mieczkowski, A. (2021) · Pharmaceuticals · doi:10.3390/ph14090851 · Cited by 20
Detection of doublecortin domain-containing 2 (DCDC2), a new candidate tumor suppressor gene of hepatocellular carcinoma, by triple combination array analysis
Inokawa, Y., Nomoto, S., Hishida, M., Hayashi, M., Kanda, M., Nishikawa, Y., Takeda, S., Sugimoto, H., Fujii, T., Yamada, S., et al. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-65 · Cited by 18
Chemical tools in chromatin research
Schwarzer, D. (2010) · Journal of Peptide Science · doi:10.1002/psc.1226 · Cited by 18
Histone-modifying enzymes: their role in the pathogenesis of acute leukemia and their therapeutic potential
Vu, L., Luciani, L., & Nimer, S. D. (2013) · International Journal of Hematology · doi:10.1007/s12185-012-1247-y · Cited by 18
“HDAC proteins counteract HAT activity; they are associated with transcriptional repression, forming macromolecular complexes with corepressor molecules, such as N-COR, but also transcription factors and nuclear receptors that sit on gene regulatory elements [24].”
Background
Novel targets for the treatment and palliation of gastrointestinal neuroendocrine tumors.
Pinchot, S. N., Pitt, S. C., Sippel, R. S., Kunnimalaiyaan, M., & Chen, H. (2008) · PubMed · Cited by 18
Design, Synthesis, and Biological Evaluation of Novel Fms-Like Tyrosine Kinase 3/VEGFR2/Histone Deacetylase Inhibitors for the Treatment of Acute Myeloid Leukemia
Tian, H., Liu, Y., Lin, S., Deng, J., Zhang, Q., Hao, F., Tang, Y., Xiong, T., Zhang, K., Shi, G., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c03084 · Cited by 17

Authors: Gallinari, P., Marco, S. D., Jones, P., Pallaoro, M., & Steinkühler, C.
Affiliations: Institute of Molecular Biology and Pathology (IT)
Corresponding author: Steinkühler, Christian
ORCID: Gallinari, Paola
Steinkühler, Christian
Venue: Cell Research
Publisher: Springer Science and Business Media LLC
Published: 2007-02-27
Volume: 17
Issue: 3
Pages: 195-211
ISSN: 1001-0602 (ISSN-L)
1748-7838
DOI: 10.1038/sj.cr.7310149
OpenAlex: W2031954417
Semantic Scholar: 755cb3e836171a20f267d47b6677a035efcf7c22
Cited by: 678
References: 165
Citations by year: 2026: 47 · 2025: 87 · 2024: 38 · 2023: 37 · 2022: 52 · 2021: 58 · 2020: 30 · 2019: 29 · 2018: 28 · 2017: 20 · 2016: 29 · 2015: 22 · 2014: 27 · 2013: 38 · 2012: 20
FWCI: 2.44
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Cell Research (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
Keywords: histone deacetylase, histone acetyltransferase, histone acetylation, gene transcription, chromatin conformation, histone deacetylase inhibitors, cancer therapeutics, non-histone protein acetylation, post-translational modification, cell cycle regulation, cell differentiation, malignant transformation
MeSH terms: Acetylation, Animals, Histone Deacetylases, Histones, Humans, Models, Biological, Models, Molecular, Molecular Biology, Neoplasms, Transcription, Genetic, Histone Deacetylase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks